Clinical Trial Update: Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

An exploratory Phase 2 clinical trial evaluating oral paclitaxel plus radiotherapy for locally advanced unresectable esophageal squamous cell carcinoma is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Oral Paclitaxel (paclitaxel)

Snippet

Sponsor: Jiangsu Cancer Institute & Hospital | Conditions: Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING